Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy

References

• JemalASiegelRWardE2008 Cancer statisticsCA Cancer J Clin200858719618287387
   PubMed Web of Science ®Google Scholar
• JarzynaPASkajaaTGianellaAIron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imagingBiomaterials2009306947695419783295
   PubMed Web of Science ®Google Scholar
• PengXQianXMaoHTargeted magnetic iron oxide nanoparticles for tumor imaging and therapyInt J Nanomed20083311321
   PubMed Web of Science ®Google Scholar
• YangLPengXWangAReceptor-targeted nanoparticles for in vivo imaging of breast cancerClin Cancer Res2009154722473219584158
   PubMed Web of Science ®Google Scholar
• ShenoyDLittleSLangerRAmijiMPoly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluationsMol Pharm2005235736616196488
   PubMed Web of Science ®Google Scholar
• BaeYDieziTAZhaoAKwonGSMixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agentsJ Control Release200712232433017669540
   PubMed Web of Science ®Google Scholar
• LeeHLeeEKimKJangNKJeongYYJonSAntibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imagingJ Am Chem Soc20061287383738916734494
   PubMed Web of Science ®Google Scholar
• KorbLRadiotherapy for the palliation of prostate cancerSemin Surg Oncol200018757910617898
   PubMedGoogle Scholar
• HartmannFHorakEMGarmestaniKRadioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-TacCancer Res199454436243708044783
   PubMed Web of Science ®Google Scholar
• KennelSJStabinMRoeskeJCRadiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cellsRadiat Res199915124425610073661
   PubMed Web of Science ®Google Scholar
• BallangrudAMYangWHCharltonDEResponse of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)Cancer Res2001612008201411280760
   PubMed Web of Science ®Google Scholar
• HummJLA microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapyInt J Radiat Oncol Biol Phys198713176717733667382
   PubMedGoogle Scholar
• GoldenbergDMTargeted therapy of cancer with radiolabeled antibodiesJ Nucl Med20024369371311994535
   PubMed Web of Science ®Google Scholar
• SalvatoriMIndovina1LMansiLTargeted α-particle therapy: a clinical overviewCurrent Radiopharmaceuticals20081251253
   Google Scholar
• ZalutskyMRTargeted a-particle therapy of microscopic disease: providing a further rationale for clinical investigationJ Nucl Med2006471238124016882999
   PubMed Web of Science ®Google Scholar
• MühlhausenUSchirrmacherRPielMSynthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imagingJ Med Chem20064926327216392811
   PubMed Web of Science ®Google Scholar
• SchipperMLRieseCGSeitzSEfficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivoEur J Nucl Med Mol Imaging20073463865017160413
   PubMed Web of Science ®Google Scholar
• MulfordDAScheinbergDAJurcicJGThe promise of targeted a-particle therapyJ Nucl Med200546199S204S15653670
   PubMed Web of Science ®Google Scholar
• MitraANanALineBRNanocarriers for nuclear imaging and radiotherapy of cancerCurrent Pharmaceutical Design2006124729474917168775
   PubMed Web of Science ®Google Scholar
• SaravanakumarGKimKParkJHCurrent status of nanoparticle-based imaging agents for early diagnosis of cancer and atherosclerosisJ Biomed Nanotechno200952035
   Web of Science ®Google Scholar
• MarcucciFLefoulonFActive targeting with particulate drug carriers in tumor therapy: fundamentals and recent progressDrug Discovery Today2004921922814980540
   PubMed Web of Science ®Google Scholar
• LiLWartchowCADanthiSNA novel antiangiogenesis therapy using an integrin or anti-FLK-1 antibody cotated 90Y-labeled nanoparticlesInt J Radiation Oncology Biol Phys20045812151227
   PubMed Web of Science ®Google Scholar
• DeNardoSJDeNardoGLMiersLADevelopment of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapyClin Cancer Res2005117087S7092S16203807
   PubMed Web of Science ®Google Scholar
• ChenJWuHHanDUsing anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancerCancer Letters200623116917516399221
   PubMed Web of Science ®Google Scholar
• NieSXingYKimGJSimonsJWNanotechnology applications in cancerAnnu Rev Biomed Eng2007925728817439359
   PubMed Web of Science ®Google Scholar
• QianXPengXHAnsariDOIn vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tagsNat Biotechnol200826839018157119
   PubMed Web of Science ®Google Scholar
• GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials2005263995402115626447
   PubMed Web of Science ®Google Scholar
• VeisehOSunCGunnJOptical and MRI multifunctional nanoprobe for targeting gliomasNano Letters200551003100815943433
   PubMed Web of Science ®Google Scholar
• XieJXuCKohlerYControlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cellsAdv Mater20071931633166
   Web of Science ®Google Scholar
• VeisehOSunCFangCSpecific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the bloodbrain barrierCancer Res2009696200620719638572
   PubMed Web of Science ®Google Scholar
• SunCLeeJSZhangMMagnetic nanoparticles in MR imaging and drug deliveryAdv Drug Deliv Rev2008601252126518558452
   PubMed Web of Science ®Google Scholar
• Briley-SaeboKBjørnerudAGrantDHepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imagingCell Tissue Res200431631532315103550
   PubMed Web of Science ®Google Scholar
• FujitaTNishikawaMOhtsuboYControl of in-vivo fate of albumin derivatives utilizing combined chemical modificationJ Drug Target199421571658069594
   PubMed Web of Science ®Google Scholar
• KairdolfBAManciniMCSmithAMMinimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatizied surface coatingsAnal Chem2008803029303418324840
   PubMed Web of Science ®Google Scholar
• LaddJZhangZChenSZwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasmaBiomacromolecules200891357136118376858
   PubMed Web of Science ®Google Scholar
• BreusVVHeyesCDTronKZwitterionic Biocompatible Quantum Dots for Wide pH Stability and Weak Nonspecific Binding to CellsACS Nano200932573258019719085
   PubMed Web of Science ®Google Scholar
• YangWZhangLWangSFunctionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serumBiomaterials2009305617562119595457
   PubMed Web of Science ®Google Scholar
• ChenHWuXDuanHBiocompatible polysiloxane-containing diblock copolymer PEO-b-P γMPS for coating magnetic nanoparticlesACS Applied Materials and Interfaces200912134214020161520
   PubMed Web of Science ®Google Scholar
• PanyamJZhouWZPrabhaSRapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J2002161217122612153989
   PubMed Web of Science ®Google Scholar
• NasongklaNBeyERenJMultifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systemsNano Letters200662427243017090068
   PubMed Web of Science ®Google Scholar
• LiuXWangYNakamuraKAuger radiation – induced, antisensemediated cytotoxicity of tumor cells using a 3-component streptavidindelivery nanoparticle with 111InJ Nucl Med20095058259019289423
   PubMed Web of Science ®Google Scholar
• WangMDShinDMSimonJWNanotechnology for targeted cancer therapyExpert Rev Anticancer Ther2007783383717555393
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdvanced Drug Delivery Reviews2004561649165915350294
   PubMed Web of Science ®Google Scholar
• van VlerkenLEVyasTKAmijiMMPoly (ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular deliveryPharmaceutical Research2007241405141417393074
   PubMed Web of Science ®Google Scholar
• Kukowska-LatalloJFCandidoKACaoZNanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancerCancer Res2005655317532415958579
   PubMed Web of Science ®Google Scholar
• WeisslederRKellyKSunEYCell-specific targeting of nanoparticles by multivalent attachment of small moleculesNat Biotechnol2005231418142316244656
   PubMed Web of Science ®Google Scholar
• LiuZCaiWHeLIn vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in miceNat Nanotechnol20072475218654207
   PubMed Web of Science ®Google Scholar
• YangLMaoHWangYYSingle chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imagingSmall2009523524319089838
   PubMed Web of Science ®Google Scholar
• ZhangCFJugoldMWoenneECSpecific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scannerCancer Res2007671555156217308094
   PubMed Web of Science ®Google Scholar
• CaiWBChenXYPreparation of peptide-conjugated quantum dots for tumor vasculature-targeted imagingNature Protocols200838996
   PubMed Web of Science ®Google Scholar
• AntonyACFolate receptorsAnnu Rev Nutr1996165015128839936
   PubMed Web of Science ®Google Scholar
• KeCYMathiasCJGreenMAFolate-receptor-targeted radionuclide imaging agentsAdv Drug Deliv Rev2004561143116015094212
   PubMed Web of Science ®Google Scholar
• DasMMishraDDhakPBiofunctionalized, phosphonategrafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imagingSmall200952883289319856326
   PubMed Web of Science ®Google Scholar
• ThomasMKularatneSAQiLLigand-targeted delivery of small interfering RNAs to malignant cells and tissuesAnn N Y Acad Sci20091175323919796075
   PubMed Web of Science ®Google Scholar
• SetuaSMenonDAsokAFolate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cellsBiomaterials20103171472919822364
   PubMed Web of Science ®Google Scholar
• RossinRPanDQiK64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biological evaluationJ Nucl Med2005461210121816000291
   PubMed Web of Science ®Google Scholar
• AlexiouHJurgonsRSchmidRJMagnetic drug targetingbiodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatmentJ Drug Targeting200311139149
   PubMed Web of Science ®Google Scholar
• RaylmanRRWahlRLMagnetically enhanced radionuclide therapyJ Nucl Med1994351571638271038
   PubMed Web of Science ®Google Scholar
• StrefferCThe biological basis for tumor therapy by hyperthermia and radiationStrefferJHyperthermia and The Therapy of Malignant TumorsBerlinSpringer1987
   Google Scholar
• MorozPJonesSKGrayBNMagnetically mediated hyperthermia: Current status and future directionsInt J Hyperthermia20038267284
   Google Scholar
• NatarajanAXiongCGruettnerCDevelopment of multivalent radioimmunonanoparticles for cancer imaging and therapyCancer Biotherapy Radiopharmaceuticals200823829118298332
   PubMed Web of Science ®Google Scholar
• NatarajanAGruettnerCIvkovRNanoferrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokineticsBioconjugate Chem20081912111218
   PubMed Web of Science ®Google Scholar
• SofouSRadionuclide carriers for targeting of cancerInt J Nanomed20083181199
   PubMed Web of Science ®Google Scholar
• AzabAKSrebnikMDovinerVTargeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymersJ Control Release2005106142516005094
   PubMed Web of Science ®Google Scholar
• YinghuaiZPengATCarpenterKSubstituted carboraneappended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug deliveryJ Am Chem Soc20051279875988015998093
   PubMed Web of Science ®Google Scholar
• MortensenaMWSørensenbPGBjorkdahlOPreparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapyApplied Radiation Isotopes20066431532416290943
   PubMed Web of Science ®Google Scholar
• LiSDHuangLNanoparticles evading the reticuloendothelial system: role of the supported bilayerBiochim Biophys Acta200917882259226619595666
   PubMed Web of Science ®Google Scholar
• FangCShiBPeiYYHongMHWuJChenHZIn vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle sizeEur J Pharm Sci200627273616150582
   PubMed Web of Science ®Google Scholar
• WilhelmCBilloteyCRogerJPonsJNBacriJCGazeauFIntracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coatingBiomaterials2003241001101112504522
   PubMed Web of Science ®Google Scholar
• LeeHYLiZChenKPET/MRI dual-modality tumor imaging using arginine-gycine-aspartic (RGD) – conjugated radiolabeled iron oxide nanoparticlesJ Nucl Med2008491371137918632815
   PubMed Web of Science ®Google Scholar
• HeXNieHWangKTanWWuXZhangPIn vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticlesAnal Chem2008809597960319007246
   PubMed Web of Science ®Google Scholar
• NahrendorfMZhangHHembradorSNanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosisCirculation200811737938718158358
   PubMed Web of Science ®Google Scholar
• JaceneHAFiliceRKasecampW18F-FDG PET/CT for monitoring the response of lymphoma to radioimmunotherapyJ Nucl Med20095081719091903
   PubMed Web of Science ®Google Scholar
• EsmaeliBMcLaughlinPProBProspective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphomaAnn Oncol20092070971419150940
   PubMed Web of Science ®Google Scholar